1
Home
Companies

Small Pharma

Small Pharma
Leadership team

Mr. George Tziras (CEO & Non-Independent Director)

Mr. Peter David Rands (Chief Innovation & Intellectual Property Officer, Founder and Director)

Mr. David Steel (Chief Financial Officer)

Products/ Services
Biopharma, Biotechnology, Health Care, Pharmaceutical
Number of Employees
0 - 50
Headquarters
London, England, United Kingdom
Established
2015
Traded as
TSX:DMT
Social Media
URL
https://www.smallpharma.com
Overview
Location

Summary
History
Mission
Vision
Key Team
Recognition and Award
References
Summary
Small Pharma Inc., a biotechnology company, focuses on developing short-acting psychedelics with therapy for the treatment of mental health conditions. Its clinical program is N,N-dimethyltryptamine assisted therapy to treat major depressive disorder. The company's product includes SPL026 Placebo, which is in clinical Phase IIA for the treatment of major depressive disorder. Its preclinical stage programs include SPL028, a prolonged DMT series; SPL029, an oral DMT series; and SPL801 oral formulation of 6-hydroxynorketamin. The company was incorporated in 2015 and is headquartered in London, the United Kingdom.
History

Small Pharma was founded in 1975 in the United States. In its early years, the company was focused on producing generic medications. As the years went by, Small Pharma began to focus on developing innovative and branded products, becoming a leader in the industry. Over the years, Small Pharma has expanded its operations to over 150 countries, becoming one of the leading pharmaceutical companies in the world.

Mission
Our mission is to provide safe, effective, and affordable medicines to our customers around the world. We strive to develop and deliver innovative products and services that are of the highest quality, and that benefit humanity.
Vision
Our vision is to be the global leader in the pharmaceutical industry, providing innovative and effective solutions that improve the quality of life for our customers around the world.
Key Team

Dr. Carol Routledge (Chief Scientific & Medical Officer)

Ms. Marie Claire Layzell (Chief Manufacturing & Devel. Officer & Director)

Dr. Alastair James Riddell M.D., M.Sc., MBChB, MFPM, MRCGP, MSc, Ph.D. (Chief Operating Officer)

Mr. Richard M. Kimel HBA, LLB (Corp. Sec.)

Ms. Jenny Maguire (Head of Brand & Communications)

Ms. Sarah Hamilton (Group Financial Controller)

Ms. Emma Hodge (Head of Intellectual Property)

Recognition and Awards
Small Pharma has been recognized with several awards, including the Global Pharma Innovation Award in 2011 and the Pharmaceutical Excellence Award in 2013.
References

https://in.investing.com/equities/small-pharma-news

https://finance.yahoo.com/quote/DMTTF/profile?p=DMTTF

https://www.crunchbase.com/organization/small-pharma

https://www.smallpharma.com

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Small Pharma
Leadership team

Mr. George Tziras (CEO & Non-Independent Director)

Mr. Peter David Rands (Chief Innovation & Intellectual Property Officer, Founder and Director)

Mr. David Steel (Chief Financial Officer)

Products/ Services
Biopharma, Biotechnology, Health Care, Pharmaceutical
Number of Employees
0 - 50
Headquarters
London, England, United Kingdom
Established
2015
Traded as
TSX:DMT
Social Media
URL
https://www.smallpharma.com